ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.188,34
-1,00%
S&P 500
5.214,08
0,51%
US Dollar vs BRL
5,1407
1,01%
Bitcoin
62.670,84
2,42%
Brent Oil
83,95
0,47%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. PAVmed Inc (PAVMZ)

  7. PAVmed Inc (PAVMZ) Notícias

PAVMZ

PAVmed (PAVMZ)

PAVmed Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:PAVMZ
DataHoraFonteTítuloCódigoCompanhia
07/05/202410:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PAVMZPAVmed Inc
17/01/202318:05Business WirePAVmed and Lucid Diagnostics Provide Strategic Business UpdateNASDAQ:PAVMZPAVmed Inc
11/01/202310:00Business WirePAVmed and Lucid Diagnostics to Provide Strategic Business UpdateNASDAQ:PAVMZPAVmed Inc
22/12/202210:25Business WirePAVmed Partners with Novosound on Ultrasound Imaging TechnologyNASDAQ:PAVMZPAVmed Inc
15/12/202210:25Business WirePAVmed Digital Health Subsidiary Veris Health Launches Veris Cancer Care PlatformNASDAQ:PAVMZPAVmed Inc
08/12/202210:25Business WireLucid Diagnostics Selected as Finalist for Medtech Company of the Year 2022 by Medical Device + Diagnostic IndustryNASDAQ:PAVMZPAVmed Inc
01/12/202210:25Business WireLucid Diagnostics Presents Real-World EsoCheck Data at the American Association for Cancer ResearchNASDAQ:PAVMZPAVmed Inc
14/11/202218:40Business WireLucid Diagnostics Provides Business Update and Third Quarter 2022 Financial ResultsNASDAQ:PAVMZPAVmed Inc
11/11/202210:25Business WirePAVmed to Participate in BTIG Digital Health ForumNASDAQ:PAVMZPAVmed Inc
10/11/202210:25Business WireLucid Diagnostics to Participate in Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services ForumNASDAQ:PAVMZPAVmed Inc
09/11/202210:25Business WireLucid Diagnostics Commences Production of EsoCheck Devices with High-Volume ManufacturerNASDAQ:PAVMZPAVmed Inc
03/11/202209:25Business WirePAVmed to Hold a Business Update Conference Call and Webcast on November 15, 2022NASDAQ:PAVMZPAVmed Inc
02/11/202209:25Business WireLucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 14, 2022NASDAQ:PAVMZPAVmed Inc
30/08/202209:25Business WirePAVmed to Participate in the Lake Street 6th Annual Best Ideas Growth Conference and the A.G.P. Virtual MedTech ConferenceNASDAQ:PAVMZPAVmed Inc
16/08/202217:40Business WirePAVmed Provides Business Update and Preliminary Second Quarter 2022 Financial ResultsNASDAQ:PAVMZPAVmed Inc
11/08/202209:25Business WireLucid Diagnostics Launches Stage II Lucid Test Center Expansion in California, Texas, Florida, and OhioNASDAQ:PAVMZPAVmed Inc
04/08/202209:25Business WireNewly Published American Gastroenterological Association Clinical Practice Update Supports Esophageal Precancer Screening Using Lucid Diagnostics’ EsoGuard® and EsoCheck® TechnologiesNASDAQ:PAVMZPAVmed Inc
19/07/202209:25Business WirePAVmed Chairman & CEO Lishan Aklog, M.D. Named to Savoy’s 2022 Most Influential Black Executives in Corporate AmericaNASDAQ:PAVMZPAVmed Inc
18/07/202209:25Business WireLucid Diagnostics to Participate in the Canaccord 42nd Annual Growth Conference and the 7th Annual Needham Med Tech & Diagnostics 1x1 ConferenceNASDAQ:PAVMZPAVmed Inc
13/05/202209:25Business WirePAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. Named Top 50 Healthcare Technology CEONASDAQ:PAVMZPAVmed Inc
28/04/202217:05GlobeNewswire Inc.PAVmed Announces Procedural Update on its Settlement of a Previously Disclosed Class Action LawsuitNASDAQ:PAVMZPAVmed Inc
26/04/202209:25Business WirePAVmed to Hold a Business Update Conference Call on May 12, 2022NASDAQ:PAVMZPAVmed Inc
29/03/202217:11Business WirePAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial ResultsNASDAQ:PAVMZPAVmed Inc
23/03/202209:25Business WirePAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test CentersNASDAQ:PAVMZPAVmed Inc
17/03/202209:25Business WirePAVmed Announces Successful First-in-Human Implantations of its PortIO™ Intraosseous Infusion SystemNASDAQ:PAVMZPAVmed Inc
10/03/202210:25Business WirePAVmed Subsidiary Veris Health Launches World-Class Technology Advisory BoardNASDAQ:PAVMZPAVmed Inc
08/03/202210:30Business WirePAVmed to Hold a Business Update Conference Call on March 29, 2022NASDAQ:PAVMZPAVmed Inc
07/03/202210:30Business WireLucid Diagnostics to Hold a Business Update Conference Call on March 28, 2022NASDAQ:PAVMZPAVmed Inc
04/03/202210:25Business WireLucid Diagnostics to Participate in the LSI USA ’22 Emerging Medtech SummitNASDAQ:PAVMZPAVmed Inc
03/03/202210:25Business WirePAVmed Subsidiary Lucid Diagnostics Launches LucidDx Labs to Accommodate EsoGuard Testing GrowthNASDAQ:PAVMZPAVmed Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:PAVMZ

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
COGN3
COGNA ON
BOV
PDTC3
Padtec ON
BOV
AZEV4
AZEVEDO PN
BOV
OIBR3
OI ON
BOV
VVEO3
CM Hospitalar ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
PRIO3
PETRORIO ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
ENJU3
Enjoei ON
BOV
HBRE3
HBR Realty Empreendiment... ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
ENAT3
ENAUTA ON
BOV
JHSF3
JHSF PART ON
BOV
SGPS3
SPRINGS ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados